Protagonist Therapeutics Inc (PTGX) is destined for greater heights as its last quarter sales were 170,640 K
A new trading day began on Tuesday, with Protagonist Therapeutics Inc (NASDAQ: PTGX) stock price up 0.11% from the previous day of trading, before settling